Publications by authors named "Thomas Moens"

Claim this Profile
C
C21ORF2 mutations point towards primary cilia dysfunction in amyotrophic lateral sclerosis.
Mathias De Decker, Pavol Zelina, Thomas G Moens, Jimmy Beckers, Matilde Contardo

Brain· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications.
Thomas G Moens, Sandrine Da Cruz, Manuela Neumann, Tatyana A Shelkovnikova, Neil A Shneider

Lancet Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo.
Liam Kempthorne, Deniz Vaizoglu, Alexander J Cammack, Mireia Carcolé, Martha J Roberts, Thomas G Moens

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Paraskevi Tziortzouda, Jolien Steyaert, Wendy Scheveneels, Adria Sicart, Katarina Stoklund Dittlau, Thomas G Moens

Acta Neuropathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation.
Pegah Masrori, Simona Ospitalieri, Karin Forsberg, Thomas G Moens, Koen Poesen

Eur J Neurol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis.
Hagai Marmor-Kollet, Aviad Siany, Nancy Kedersha, Naama Knafo, Natalia Rivkin, Thomas G Moens

Mol Cell· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A.
Thomas G Moens, Teresa Niccoli, Katherine M Wilson, Magda L Atilano, Nicol Birsa

Acta Neuropathol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD.
Thomas G Moens, Sarah Mizielinska, Teresa Niccoli, Jamie S Mitchell, Annora Thoeng

Acta Neuropathol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-quadruplex-binding small molecules ameliorate FTD/ALS pathology and .
Roberto Simone, Rubika Balendra, Thomas G Moens, Elisavet Preza, Katherine M Wilson

EMBO Mol Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific biomarkers for FTD/ALS could expedite the journey towards effective therapies.
Rubika Balendra, Thomas G Moens, Adrian M Isaacs

EMBO Mol Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic models of C9orf72: what is toxic?
Thomas G Moens, Linda Partridge, Adrian M Isaacs

Curr Opin Genet Dev· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.
Mar Matarin, Dervis A Salih, Marina Yasvoina, Damian M Cummings, Sebastian Guelfi, Thomas G Moens

Cell Rep· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins.
Sarah Mizielinska, Sebastian Grönke, Teresa Niccoli, Charlotte E Ridler, Emma L Clayton, Thomas Moens

Science· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.
Sian E Davies, Penelope J Hallett, Thomas Moens, Gaynor Smith, Emily Mangano

Neurobiol Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis